BioSpace News Archive

BioForest

Trump’s SOTU Claim of Biggest Decline in Prescription Drug Prices Is for a One Month Period

During the president’s annual address to Congress and the nation, Trump said that as a result of his administration’s efforts to lower the costs of prescription drugs, “in 2018 drug prices experienced their single largest decline in 46 years.”

February 6, 2019

·

2 min read

·

Alex Keown

Business

Gladstone Institutes’ Robert Mahley Launches Alzheimer’s Biotech GABAeron

Robert Mahley, founder and president of Gladstone Institutes, an internationally-recognized expert on heart disease, cholesterol metabolism and Alzheimer’s disease, is launching a biotech company to focus on Alzheimer’s disease. The company is called GABAeron.

February 6, 2019

·

3 min read

·

Mark Terry

Business

GSK Cuts Six Respiratory Assets as It Continues to Focus on Oncology Treatments

GlaxoSmithKline has been in the midst of a significant reshaping to focus on pharmaceuticals, particularly a renewed interest in oncology treatments. As a result, the company has made some cuts to its pipeline, including six quietly announced this morning in the company’s year-end report.

February 6, 2019

·

3 min read

·

Alex Keown

Improving sustainability in commercial laundry

Syrris provides award-winning chemistry products to a range of research and development chemists and engineers, including Xeros Technology Group, a company specializing in novel and sustainable polymer solutions to advance the commercial laundry industry.

February 6, 2019

·

2 min read

Amprologix secures funding to develop new antibiotic with Ingenza

Ingenza is pleased to announce that University of Plymouth spin-out Amprologix, in which it has a stake, has been awarded a £1.2 million contract from the UK Department of Health and Social Care to accelerate the development and scale up its lead antibiotic candidate, Epidermicin NI01.

February 6, 2019

·

2 min read

Business

BioSpace’s Global Biopharma Roundup: Feb. 7

Across the globe, pharma companies are making an impact. Last week BioSpace launched the first of a weekly roundup of international biotech and pharma news. Here’s the latest edition.

February 6, 2019

·

5 min read

·

Alex Keown

Business

Dr. Peter Kaspar Joins First Light Diagnostics Board of Directors

First Light Diagnostics announced the addition of Dr. Peter Kaspar to the company’s board of directors effective January 1, 2019.

February 6, 2019

·

2 min read

Business

Jennewein Biotechnologie and Yili Group join forces in China for microbiome research and human milk oligosaccharides to bring innovation to the largest baby food market

China represents the largest market for baby food globally

February 6, 2019

·

4 min read

Business

MorphoSys Announces Appointment of David Trexler as President and Member of the Board of Directors of MorphoSys US Inc.

MorphoSys AG announced the appointment of David R. Trexler as President and member of the Board of Directors of MorphoSys US Inc., effective February 6, 2019.

February 6, 2019

·

5 min read

Drug Development

MacroGenics Soars on Phase III Breast Cancer Study

Shares of Rockville, Md.-based MacroGenics, Inc. have skyrocketed nearly 160 percent in premarket trading after the company announced its Phase III HER2-positive metastatic breast cancer study hit the mark.

February 6, 2019

·

2 min read

·

Alex Keown